Literature DB >> 24649030

A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.

Jing Wu1, Xuan Guan2, Kui Zhang3, Ya-Ting Li1, Peng Bai3, Jin Wu1.   

Abstract

This meta-analysis was conducted to evaluate the effect of the matrix metalloproteinase 7 (MMP7)-181A/G polymorphism on cancer risk. Twenty-seven case-control studies were identified via a literature search through PubMed, Web of Science and China National Knowledge Infrastructure databases. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were applied to assess the strength of the association between MMP7-181A/G polymorphism and cancer risk. The 27 studies were further assessed according to Hardy-Weinberg equilibrium (HWE) and Hardy-Weinberg disequilibrium (HWD), with 24 case-control studies found to be under HWE. A significant association was observed between MMP7-181A/G polymorphism and increased cancer risk (cervical and other types of cancer) in Asian, but not in European populations.

Entities:  

Keywords:  cancer risk; matrix metalloproteinase; meta-analysis; polymorphism

Year:  2013        PMID: 24649030      PMCID: PMC3917052          DOI: 10.3892/br.2013.131

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  30 in total

1.  Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.

Authors:  Giorgio Ghilardi; Maria Luisa Biondi; Maddalena Erario; Emma Guagnellini; Roberto Scorza
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

Review 3.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

4.  No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Wei Qiu; Gangqiao Zhou; Yun Zhai; Xiumei Zhang; Weimin Xie; Hongxing Zhang; Hao Yang; Lianteng Zhi; Xiaoyan Yuan; Xiaoai Zhang; Fuchu He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

5.  A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.

Authors:  Lukasz Dziki; Karolina Przybyłowska; Ireneusz Majsterek; Radzisław Trzciński; Michał Mik; Andrzej Sygut
Journal:  Pol Przegl Chir       Date:  2011-11

6.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

7.  Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.

Authors:  Wen-Liang Fang; Wei-Bo Liang; Huan He; Yi Zhu; Shi-Liu Li; Lin-Bo Gao; Lin Zhang
Journal:  DNA Cell Biol       Date:  2010-07-27       Impact factor: 3.311

Review 8.  Mapping proteolytic cancer cell-extracellular matrix interfaces.

Authors:  Katarina Wolf; Peter Friedl
Journal:  Clin Exp Metastasis       Date:  2008-07-04       Impact factor: 5.150

9.  Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.

Authors:  Manzoor A Malik; Kiran L Sharma; Showket A Zargar; Balraj Mittal
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

10.  Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population.

Authors:  Priyanka Srivastava; Ruchika Gangwar; Rakesh Kapoor; Rama D Mittal
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

View more
  2 in total

1.  Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.

Authors:  Steven T Sizemore; Gina M Sizemore; Christine N Booth; Cheryl L Thompson; Paula Silverman; Gurkan Bebek; Fadi W Abdul-Karim; Stefanie Avril; Ruth A Keri
Journal:  Breast Cancer Res Treat       Date:  2014-05-22       Impact factor: 4.872

Review 2.  The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma.

Authors:  Han-Yu Jiang; Hui-Min Zheng; Cheng Xia; Xiang Li; Gang Wang; Tong Zhao; Xiao-Nan Cui; Ruo-Yu Wang; Ying Liu
Journal:  Onco Targets Ther       Date:  2022-03-22       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.